Pioglitazone on Pancreatic Steatosis and Bone Health
| Status: | Completed |
|---|---|
| Conditions: | Obesity Weight Loss, Diabetes |
| Therapuetic Areas: | Endocrinology |
| Healthy: | No |
| Age Range: | 21 - 99 |
| Updated: | 12/15/2017 |
| Start Date: | February 2009 |
| End Date: | December 2013 |
Effect of Pioglitazone on Pancreatic Steatosis and Bone Health
Randomized, double blind, placebo controlled trial evaluating the effect of pioglitazone on
pancreatic fat content and bone turnover markers.
pancreatic fat content and bone turnover markers.
Inclusion Criteria:
- Fat level in the pancreas above 4% (measurement done by us with an MRI)
- English speaker
- over 21 years old
Exclusion Criteria:
- contraindication to MRI
- anemia
- pregnancy or desire to conceive
- use of unapproved medications
- prior pancreatic disease
- use of more then 2 alcoholic drinks every day
We found this trial at
1
site
U.T. Southwestern Medical Center The story of UT Southwestern Medical Center is one of commitment...
Click here to add this to my saved trials
